These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of human tumors. Sinkovics JG Pathobiol Annu; 1978; 8():241-84. PubMed ID: 364375 [No Abstract] [Full Text] [Related]
7. [Monoclonal antibodies against tumor-associated antigens of the gastrointestinal tract. Experimental and clinical outlook]. Schmiegel WH; Kalthoff H Dtsch Med Wochenschr; 1985 Dec; 110(50):1943-9. PubMed ID: 3908048 [No Abstract] [Full Text] [Related]
8. Tumor therapy with monoclonal antibodies. Levy R; Miller RA Fed Proc; 1983 Jun; 42(9):2650-6. PubMed ID: 6343125 [No Abstract] [Full Text] [Related]
9. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody]. Kon S Gan To Kagaku Ryoho; 1988 May; 15(5):1685-92. PubMed ID: 3259417 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types. Ascierto PA; Kalos M; Schaer DA; Callahan MK; Wolchok JD Clin Cancer Res; 2013 Mar; 19(5):1009-20. PubMed ID: 23460532 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis. Stellas D; Karameris A; Patsavoudi E Clin Cancer Res; 2007 Mar; 13(6):1831-8. PubMed ID: 17363539 [TBL] [Abstract][Full Text] [Related]
12. Active and passive immunotherapy for lymphoma: proving principles and improving results. Brody J; Kohrt H; Marabelle A; Levy R J Clin Oncol; 2011 May; 29(14):1864-75. PubMed ID: 21482977 [TBL] [Abstract][Full Text] [Related]
13. [Prognosis and treatment of malignant digestive lymphomas. I. Primary lymphomas of the digestive tract should be treated like other malignant non-Hodgkin's lymphomas. Systematic laparotomy is not indispensable]. Hoerni B; Rougier P Gastroenterol Clin Biol; 1984 May; 8(5):430-1. PubMed ID: 6735056 [No Abstract] [Full Text] [Related]
14. [Use of antibodies or their fragments for the treatment of tumors]. Douillard JY; Chatal JF Bull Cancer; 1998 Nov; 85(11):951-9. PubMed ID: 9951422 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies in the diagnosis and treatment of malignant conditions. Allum WH; Macdonald F; Fielding JW Surg Annu; 1986; 18():41-64. PubMed ID: 2417343 [No Abstract] [Full Text] [Related]
16. Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities. Wong ET Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7151s-7157s. PubMed ID: 16203815 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies in the treatment of hematopoietic malignancies. Houghton A; Scheinberg D Semin Hematol; 1988 Jul; 25(3 Suppl 3):23-9. PubMed ID: 3051406 [TBL] [Abstract][Full Text] [Related]
18. [Clinical application of monoclonal antibodies to human malignant melanoma-associated antigens]. Kageshita T; Ishihara K Gan To Kagaku Ryoho; 1985 Sep; 12(9):1744-8. PubMed ID: 3899015 [TBL] [Abstract][Full Text] [Related]
19. [Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies]. Castello G; D'Alessio V Clin Ter; 1991 May; 137(3):155-67. PubMed ID: 1831084 [TBL] [Abstract][Full Text] [Related]
20. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas. Routhier CA; Mochel MC; Lynch K; Dias-Santagata D; Louis DN; Hoang MP Hum Pathol; 2013 Nov; 44(11):2563-70. PubMed ID: 24071017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]